Tenders/Shandong First Medical University (Shandong Academy of Medical Sciences) Tumor Cell Therapy and Biomedical New Technology Clinical Translation Center Equipment Procurement Project I Public Bidding Announcement

Open🇨🇳ChinaSupplies

Shandong First Medical University (Shandong Academy of Medical Sciences) Tumor Cell Therapy and Biomedical New Technology Clinical Translation Center Equipment Procurement Project I Public Bidding Announcement

Auto-translated from Chinese

Original title: 山东第一医科大学（山东省医学科学院）肿瘤细胞治疗与生物医学新技术临床转化中心设备购置项目一公开招标招标公告

山东第一医科大学

Published: Nov 4, 2026

Updated: Nov 4, 2026

Source: China CCGP

About This Opportunity

This is a supplies contract in the health and medical services, Research and general supplies sectors, with a focus on Medical Equipment, Laboratory, Innovation and Laboratories. Located in China, Asia, this opportunity is open to firms and consortiums.

Published through China CCGP, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: Chinese

This tender is for the procurement of equipment for the Clinical Translation Center for Tumor Cell Therapy and Biomedical New Technologies at Shandong First Medical University (also known as Shandong Provincial Academy of Medical Sciences) in China. This is the first phase of equipment acquisition. The contracting authority is Shandong First Medical University, and the tender is managed by Shandong Huarun Yongwang Tendering Co., Ltd. The project aims to equip a specialized research and development center focused on advancing cancer therapies and innovative biomedical technologies. The equipment sought is likely to be highly specialized and technologically advanced, supporting research in areas such as cell therapy, gene editing, molecular biology, and advanced diagnostics. Typical requirements include state-of-the-art laboratory instruments, cell culture facilities, imaging equipment, analytical instruments, and potentially specialized manufacturing or processing equipment for clinical translation. Bidders must provide detailed technical specifications, demonstrating compliance with research standards, and offering robust installation, training, and after-sales support. Evaluation criteria will heavily weigh the scientific suitability and technical specifications of the equipment, vendor qualifications, and overall value. This investment is critical for fostering cutting-edge biomedical research and innovation.

Data provenance

This notice is sourced from China CCGP and was originally published on November 4, 2026. Last refreshed 2 days ago. Original language: Chinese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About 山东第一医科大学

山东第一医科大学 has issued 18 procurement notices on BidsFactory, including 3 currently open and 0 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Research & Innovation. All notices are published for China. Notices are distributed via China CCGP. Most recent publication: November 5, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit China CCGP to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by 山东第一医科大学 in China. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in China. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.